Abstract
Quizartinib is an oral, highly potent, and selective type II FMS-like tyrosine kinase 3 inhibitor in development for acute myeloid leukemia. This para......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
